A subgroup analysis was performed from data collected in a phase @ study of intravenous ( IV ) fosaprepitant or oral aprepitant , plus the @-HT @ antagonist ondansetron and the corticosteroid dexamethasone , in cisplatin-nave patients with solid malignancies .